NCT00962520: Tarceva With Chemoradiation and Adjuvant Chemotherapy for Resectable Pancreatic Cancer |
|
|
| Active, not recruiting | 2 | 40 | US | Erlotinib, Tarceva, capecitabine, Xeloda, Radiation Therapy, gemcitabine, Gemzar, erlotinib | Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Genentech, Inc. | Pancreatic Cancer | 04/22 | 04/23 | | |
NCT02327468: Inovio TRT-001: Telomerase DNA Immunotherapy in Breast, Lung, and Pancreatic Cancers |
|
|
| Recruiting | 1 | 54 | US | INO-1400, hTERT, INO-9012, IL-12 | Inovio Pharmaceuticals, Abramson Cancer Center of the University of Pennsylvania, University of North Carolina, Thomas Jefferson University, Wayne State University | Breast Cancer, Lung Cancer, Pancreatic Cancer, Head and Neck Squamous Cell Cancer, Ovarian Cancer, Colorectal Cancer, Gastric Cancer, Esophageal Cancer, Hepatocellular Cancer | 12/17 | 04/18 | | |